BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2016
View Archived Issues
Prexton Therapeutics starts phase I trial of Parkinson's disease candidate PXT-002331
Read More
Bristol-Myers Squibb offers overview of fourth quarter 2015
Read More
Genetic inhibition of JNK3 reduces the burden of illness in SMA
Read More
Anti-RSPO antibodies show potential for the development of cancer therapies
Read More
Development Center for Biotechnology and DCB-USA LLC patent B-Raf and C-Raf inhibitors
Read More
Gruenenthal describes PDE4B inhibitors
Read More
OptiNose announces pipeline project to evaluate unique nasal drug delivery technology
Read More
The Trinity College and InvivoGen divulge NOD1 agonists
Read More
Aduro Biotech receives clinical development milestone payments from Janssen
Read More
ARIAD receives FDA clearance to begin clinical development of AP-32788
Read More
Tenax updates status of ongoing phase III trial of levosimendan in cardiac surgery
Read More
Dickkopf-3 identified as a promoter of renal atrophy and fibrosis
Read More
Daiichi Sankyo presents accomplishments of third quarter of fiscal 2015
Read More
Matinas BioPharma cleared to initiate phase I clinical study of MAT-2501
Read More
BMS and Pfizer license Japanese rights to anticoagulant antidote
Read More
Transition Therapeutics reports phase II results for oxyntomodulin analogue TT-401
Read More
Astellas to codevelop CLINO's gene therapy candidate for retinitis pigmentosa
Read More
Mission Therapeutics raises funding to develop deubiquitinating enzyme modulators
Read More
Ziarco starts phase IIa trial of ZPL-389 in psoriasis
Read More
Extracellular delivery of anticancer agents achieved with intratumoral nanocarrier drug depots
Read More
FDA awards fast track designation to PTI-428 for cystic fibrosis
Read More
Ryanodex earns FDA fast track designation for exertional heat stroke
Read More
Phase IIa topline results for AIR-001 in HFpEF; new HFN-supported study planned
Read More
